James E. A. Zlosnik
Department of Pediatrics,
Centre for Understanding and Preventing Infection in Children,
Department of Pediatrics, Centre for Understanding and Preventing Infection in Children
University of British Columbia
James E. A. Zlosnik has not added Biography.
If you are James E. A. Zlosnik and would like to personalize this page please email our Author Liaison for assistance.
Defects in a quinol oxidase lead to loss of KatC catalase activity in Pseudomonas aeruginosa: KatC activity is temperature dependent and it requires an intact disulphide bond formation system.
Biochemical and biophysical research communications Mar, 2006 | Pubmed ID: 16430860
Investigation of the physiological relationship between the cyanide-insensitive oxidase and cyanide production in Pseudomonas aeruginosa.
Microbiology (Reading, England) May, 2006 | Pubmed ID: 16622057
Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.
Advances in microbial physiology , 2007 | Pubmed ID: 17027370
Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.
Journal of clinical microbiology Apr, 2008 | Pubmed ID: 18256220
Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions.
BMC microbiology , 2008 | Pubmed ID: 18588687
The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis.
The Journal of infectious diseases Sep, 2010 | Pubmed ID: 20670172
Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections.
American journal of respiratory and critical care medicine Jan, 2011 | Pubmed ID: 20709823
Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.
mBio , 2010 | Pubmed ID: 20856824
Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis.
The Journal of infectious diseases Feb, 2011 | Pubmed ID: 21208930
In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides.
Antimicrobial agents and chemotherapy May, 2011 | Pubmed ID: 21321142
Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?
Frontiers in microbiology , 2010 | Pubmed ID: 21687721
Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
Microbiology (Reading, England) Nov, 2011 | Pubmed ID: 21835880
Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.
Frontiers in cellular and infection microbiology , 2012 | Pubmed ID: 22919658
Metabolite profiling to characterize disease-related bacteria: gluconate excretion by Pseudomonas aeruginosa mutants and clinical isolates from cystic fibrosis patients.
The Journal of biological chemistry May, 2013 | Pubmed ID: 23572517
Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere.
Systematic and applied microbiology Oct, 2013 | Pubmed ID: 23867250
Total Protein Extraction and 2-D Gel Electrophoresis Methods for Burkholderia Species
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。